iShares Biotechnology ETF
891 hedge funds and large institutions have $5.39B invested in iShares Biotechnology ETF in 2022 Q1 according to their latest regulatory filings, with 81 funds opening new positions, 258 increasing their positions, 328 reducing their positions, and 132 closing their positions.
Holders
891
Holders Change
-64
Holders Change %
-6.7%
% of All Funds
14.1%
Holding in Top 10
13
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+30%
% of All Funds
0.21%
New
81
Increased
258
Reduced
328
Closed
132
Calls
$285M
Puts
$254M
Net Calls
+$31.5M
Net Calls Change
-$12.1M
Top Buyers
| 1 |
1
Bank of America
Charlotte,
North Carolina
|
$1.61B |
| 2 |
2
Jane Street
New York
|
$85.2M |
| 3 |
3
Goldman Sachs
New York
|
$204M |
| 4 |
4
Bessemer Group
Woodbridge,
New Jersey
|
$51.4M |
| 5 |
5
Citigroup
New York
|
$257M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1026
Capstone Investment Advisors
New York
| $0 | 3 | – | – |
|
1027
Squarepoint
New York
| – | – | – | – |
|
|
SA
1028
SpiderRock Advisors
Wilimington,
Delaware
| – | – | – | – |
|
|
UOC
1029
UBS O'Connor
Chicago,
Illinois
| – | – | – | – |
|
|
OAJ
1030
Ogorek Anthony Joseph
Williamsville,
New York
| – | – | – | – |
|
1031
Geode Capital Management
Boston,
Massachusetts
| – | – | – | – |
|
|
CAM
1032
CenterStar Asset Management
Chicago,
Illinois
| – | – | – | – |
|
|
FMP
1033
Financial Management Professionals
Austin,
Texas
| $0 | 3 | – | – |
|